Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,458 | -3,877 | -7,392 | N/A | N/A |
| Depreciation Amortization | 11 | 20 | 18 | N/A | N/A |
| Accounts payable and accrued liabilities | 657 | 154 | 71 | N/A | N/A |
| Other Working Capital | 834 | -426 | 84 | N/A | N/A |
| Other Operating Activity | 638 | 576 | 6,502 | 0 | 0 |
| Operating Cash Flow | $-7,318 | $-3,554 | $-716 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18 | -20 | N/A | N/A | N/A |
| Investing Cash Flow | $-18 | $-20 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 300 | N/A | N/A |
| Common Stock Issued | 14,222 | 10,295 | 977 | N/A | N/A |
| Other Financing Activity | -88 | -35 | -116 | 0 | 0 |
| Financing Cash Flow | $14,134 | $10,260 | $1,161 | $N/A | $N/A |
| Beginning Cash Position | 7,241 | 555 | 111 | N/A | N/A |
| End Cash Position | 14,040 | 7,241 | 555 | N/A | N/A |
| Net Cash Flow | $6,798 | $6,686 | $445 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,318 | -3,554 | -716 | N/A | N/A |
| Capital Expenditure | -18 | -20 | N/A | N/A | N/A |
| Free Cash Flow | -7,336 | -3,574 | -716 | 0 | 0 |